SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001551163-14-000006
Filing Date
2014-02-14
Accepted
2014-02-13 19:52:03
Documents
10
Period of Report
2013-12-31

Document Format Files

Seq Description Document Type Size
1 sangui10qdec2013_jf140211ved.htm 10-Q 251048
2 exhibit3101.htm EX-31 6780
3 exhibit3102.htm EX-31 7411
4 exhibit3201.htm EX-32 4255
  Complete submission text file 0001551163-14-000006.txt   1094526

Data Files

Seq Description Document Type Size
5 sgbi-20131231.xml EX-101.INS 56660
6 sgbi-20131231.xsd EX-101.SCH 13755
7 sgbi-20131231_cal.xml EX-101.CAL 14581
8 sgbi-20131231_def.xml EX-101.DEF 10288
9 sgbi-20131231_lab.xml EX-101.LAB 78511
10 sgbi-20131231_pre.xml EX-101.PRE 65681
Mailing Address 291 SOUTH 200 WEST P.O. BOX 832 FARMINGTON UT 84025
Business Address 291 SOUTH 200 WEST P.O. BOX 832 FARMINGTON UT 84025 011 49 1607 412717
SANGUI BIOTECH INTERNATIONAL INC (Filer) CIK: 0001104280 (see all company filings)

IRS No.: 841330732 | State of Incorp.: CO | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 000-29233 | Film No.: 14608934
SIC: 2834 Pharmaceutical Preparations